Effect of Core Stability Exercises on Hand Functions in Children With Hemiparesis

Background: Impaired upper extremity is the major disability facing the children with hemiplegia as the inability to use hands for reach; grasp and manipulation affect their daily life activities. little attention has been given to gain perspective about abnormal movements that are detectable in hemiplegic cerebral palsy that are related to one's level of core stability and how they affect their hand functions.

Study Overview

• Status: Completed
• Conditions: Cerebral Palsy
• Intervention / Treatment: Other: CORE STABILITY EXERCISES

Detailed Description

Background: Impaired upper extremity is the major disability facing the children with hemiplegia as the inability to use hands for reach; grasp and manipulation affect their daily life activities. little attention has been given to gain perspective about abnormal movements that are detectable in hemiplegic cerebral palsy that are related to one's level of core stability and how they affect their hand functions.

Objective: The purpose was to investigate the effectivness of core stability exercises on hand functions in hemiplegic cerebral palsy.

Methods: Thirty hemiparetic cerebral palsied children of both sexes, ranged in age from 6 to 8 years enrolled in this study. They randomly assigned into two groups of equal number. Group (A) received the selective physiotherapy exercises and group (B) received the same selective physiotherapy exercises program in addition to core stability exercises three times/week for 60 min for 12 weeks. Time motor performance, gross manual dexterity and skills of the upper extremity were assessed by using Jebsen Taylor Test (JTHFT), Box and Block Test (BBT) and Quality Upper Extremity Skill Test (QUEST) respectively before and after treatment.

• Study Type: Interventional
• Enrollment (Actual): 52
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Egypt
  • Cairo, Egypt
    • Badr Univesity in Cairo (BUC)

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 6 years to 8 years (CHILD)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• The level of gross motor function ranged from II to III, according to Gross Motor Function Classification System
• All participants are cognitively capable and competent of interpreting and following instructions

Exclusion Criteria:

• if they had fixed contractures or deformities of the spine, upper or lower extremities,
• visual or respiratory disorders, orthopedic surgery on their involved upper extremity;
• dorsal rhizotomy;
• botulinum toxin therapy in the upper extremity musculature during the past 6 months
• who wished to receive it within the period of study

Study Plan

How is the study designed?

Design Details

• Primary Purpose: TREATMENT
• Allocation: RANDOMIZED
• Interventional Model: PARALLEL
• Masking: SINGLE

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
NO_INTERVENTION: CONTROL GROUP; received the selective physiotherapy exercises
EXPERIMENTAL: STUDY GROUP; received the same selective physiotherapy exercises program in addition to core stability exercises three times/week for 60 min for 12 weeks	Other: CORE STABILITY EXERCISES; SELECTED CORE EXERCISES

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Jebsen Taylor Test	scale used to asses gross manual dexterity	Jebsen Taylor Test used to assess gross manual dexterity before the intervention and after three months of the intervention . the loweest score indicate improvement

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Box and Block Test	scale used to asses gross manual dexterity	Box and Block Test used to asses gross manual dexterity pre and after 3 months of intervension
Quality Upper Extremity Skill Test	scale used to asses skills of the upper extremity	Quality Upper Extremity Skill Test scale used to asses skills of the upper extremity pre and after 3 months of intervension

Collaborators and Investigators

• Sponsor: hanaa mohsen

Study record dates

Study Major Dates

• Study Start (ACTUAL): January 22, 2020
• Primary Completion (ACTUAL): March 20, 2020
• Study Completion (ACTUAL): March 31, 2020

Study Registration Dates

• First Submitted: January 21, 2020
• First Submitted That Met QC Criteria: January 28, 2020
• First Posted (ACTUAL): January 29, 2020

Study Record Updates

• Last Update Posted (ACTUAL): January 28, 2021
• Last Update Submitted That Met QC Criteria: January 26, 2021
• Last Verified: January 1, 2021

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Neurologic Manifestations; Brain Damage, Chronic; Cerebral Palsy; Paresis
• Other Study ID Numbers: Hana 2

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No